Medicxi Fund V
Share
N°01 / About
About Medicxi Fund V
EUR 500M (about $581M) biotech fund combining company creation and investment in existing companies using an asset-centric approach, focused on a single asset per company and typically holding 50%+ ownership in self-funded early-stage companies.
Investor Signals Profile
active
Sweet Spot
Clinical/Phase 3 biotech founders targeting $100M+ pharma exits
29 signals on Medicxi Fund V
12 bullish · 2 contrarian · 10 pitch do's · 3 don'ts · 2 GP profiles, each with its source. From €9/month, cancel anytime.